GHB Addiction & Withdrawal Syndrome
Fact Sheet -
www.project.ghb.org
By Trinka Porrata
Internet
dribble to the contrary, gamma hydroxybutyrate (GHB) is an addictive drug. Withdrawal can be severe and prolonged. Yet recognition and treatment of GHB
addiction/withdrawal isn’t readily available.
Knowledge of GHB by the public and in the fields of law
enforcement/medicine is typically limited to its abuse as an intoxicant and use
as a rape weapon. GHB addiction is
characterized by around the clock dosing (every one to three hours, day/night,
with heavier doses at night to achieve sleep).
Addiction can develop in a few weeks.
Use for four to eight months is common among the 600 GHB addicts who
have come forward for help through the GHB Addiction Helpline via www.projectghb.org. Others have been using for up to ten years,
making it impossible to know at what point they became addicted.
Occasional users are at risk from rape, overdose and death,
but are not as likely to become addicted.
Those using GHB on a daily or systematic basis as an anti-depressant, a
sleep aid, a workout aid, weight loss product, an anti-aging substance, etc.,
are at risk of addiction by virtue of their pattern of regular, frequent
use. From a nightly sleep aid, for
example, use casually moves into a morning “wake up” aid. Then it is needed in the afternoon, to have
sex, to go out in public, etc., until it has progressed to around the clock
use. Often the pattern develops without
the user realizing what is happening since they typically didn’t see it as a
“drug” or unsafe in any way because of Internet assurances. Initially users feel they have found the
perfect supplement and swear by the incredible benefits they feel they are
seeing. Stage two, however, comes when
the honeymoon is over but the user is the last to know. Friends, spouses, and co-workers begin to
observe bizarre behavior changes, frequently with no idea of the cause.
Episodes may be as subtle as a single “head snap” that occurs about 15 minutes
after taking a dose, or may be several minutes of twitching, strange behavior,
or black outs. These episodes may occur
only following the heavier nighttime doses or after virtually every dose. Thus, breaking the bathroom mirror while
getting ready for bed, or being found or waking up on the bathroom floor with a
bloody (or broken) nose is not uncommon as a result of the “head snap,” which
may result in hitting the mirror or the edge of the sink. Frequently, the addict has no recall of such
incidents. The addict grows distant from
spouse, family, and friends and may begin to withdraw from public contact or
become captivated by pornography or strip joints, which may be a total behavior
change from that exhibited prior to GHB use.
GHB addicts typically report numerous drunk/drugged driving episodes,
which are frequently unidentified or unrecognized by law enforcement officers,
especially if there has been no use of alcohol or other drugs. Many addicts report damage of “unknown
origin” appearing on their cars and being uncertain where their car may be
found in the morning, again due to the lack of memory of incidents occurring
while they were intoxicated.
*Bodybuilders/other athletes, including pros, using GHB for
a sleep or workout aid or weight loss tool--the largest group.
*Business professionals who travel frequently and were introduced to GHB as a “safe” sleep aid.
*The elderly, who have been told that GHB is an anti-aging compound.
*People with prior depression, who have been told that GHB is an anti-depressant. Intoxicating effects of GHB may make it seem, initially, to have this effect, but it later turns on many of them.
*People subject to drug testing programs who use GHB as an alcohol substitute and to bypass testing.
*Website managers, especially those selling GHB and other sports/dietary supplements, and computer programmers.
NOTE: Although GHB can be identified in tests, it remains in body fluids for a relatively short period of time compared to other drugs; it lasts in blood for four hours and in urine for twelve hours. However, GHB is not yet included in the normal testing procedures of most agencies. .
The product ingested may be actual GHB, ranging from home
brew to foreign pharmaceutical grade. It
is often an analog of GHB, a chemical cousin that converts to GHB in the
body. This may be gamma butyrolactone
(GBL) or 1,4-butanediol (BD). GBL (aka 2(3)H furanone dihydroxy) is both a
precursor (primary ingredient in making GHB) and an active analog (converts in
the body to GHB, with the same effects).
BD is an active analog. Another
analog is gamma hydroxyvalerate (GHV).
GBL, BD and GHV are available at gyms, chemical supply stores, and via
Internet mail order. They are sold as powders, capsules, gels or liquids and
can be found in a variety of concentrations, colors, and flavors. There are more than 80 street/trade names for
GHB/analogs. GBL especially may be
found in the hardware story are a primary ingredient in legitimate paint
strippers; this level of abuse is particularly dangerous as these products
contain other ingredients. Bogus
Internet products are typically disguised as “ink jet cartridge cleaners,”
“fingernail polish removers,” etc.
GHB addicts typically experience frequent overdoses or
mini-overdoses. Thus, they are often
treated as overdose victims, with no recognition of the underlying addiction
that causes these frequent episodes. GHB
has a steep dosage response curve and, even with development of tolerance, its
effects vary greatly. Addicts may dose
in one of two patterns—1) Precise dosing in regular intervals separated by one
to three hours, with slightly higher doses at night for sleep; or 2—Around the
clock “sipping” from a bottle of diluted product. Constant sipping is most likely to produce mini-overdoses.
Even with precise dosing, effects may vary based on tiny variations in dose,
differences in food intake, lack of food, or other unknown reasons. A CEO of a major corporation relayed that he
would try to adjust his dose for meetings (dose at
Missing
a dose by more than a few hours sends the addict into significant withdrawal
symptoms. This is first characterized by
profuse sweating, anxiety attacks, and may be accompanied by soaring blood
pressure and pulse. BP at dangerous
levels has been documented. This may
subside on its own after two or three days or in response to medication. Thus, on day three, a patient may “seem” to
be doing “fine” and may be released from a treatment center unfamiliar with GHB
withdrawal. The second phase of withdrawal,
which may include hallucinations and altered mental state, may begin earlier,
but may also be delayed to around day four or five. Thus, a patient released from a treatment
center on day three was found by his frantic wife hours later wandering through
the city streets, hallucinating, confused and in danger of wandering into
traffic. Sometimes, clinicians assume
addicts to be psychotic and fail to recognize the underlying
addiction/withdrawal.
Treatment of the GHB withdrawal syndrome is not yet clearly
defined. Treatment may involve use of benzodiazepines, antipsychotic
medications, or phenobarbital. It should
be noted that although tapering GHB doses prior to detoxification may help
reduce the severity of the withdrawal, attempts of some addicts to
self-detoxify, without medical assistance, have been fatal, as the withdrawal
syndrome may be severe and unpredictable.
Further, as most addicts are unable to tolerate the ongoing symptoms of
withdrawal, this method is frequently unsuccessful as well as dangerous.
1—Miotto and Roth, March 2001 article “GHB Withdrawal
Syndrome,” posted on the Texas Commission on Alcohol and Drug Abuse website (www.tcada.state.tx.us) describe the
severe withdrawal symptoms and recommend treatment involving an aggressive 7-14
day inpatient strategy with close follow up.
They note “Benzodiazepines such as lorazepam, chlordiazepoxide and
diazepam are useful in ameliorating some of the signs and symptoms of GHB
withdrawal. Loading doses of oral or
intravenous benzodiazepines do not decrease the likelihood of withdrawal
delirium, but are important for controlling psychotic agitation.” This may require high doses of benzos. Anticonvulsants and antipsychotics are also
discussed. Antihypertensive medications
may be needed in early stages to deal with the racing heart and blood pressure
issues. NOTE: Another doctor who has dealt with numerous
GHB withdrawal cases reported a preference for clorazepate over other benzos
and stresses the need to employ an antipsychotic (such as olanzapine) before
psychosis develops.
2—Silvilotti, Burns, Aaron and Greenberg, December 2001 Annals of Emergency Medicine, discuss use of phenobarbital for withdrawal from GHB and discuss five patients presenting with severe withdrawal from GBL, resulting in admission to the ICU. They report a median hospital stay of five days. Bear in mind, each patient had already endured four or five days without GHB/GBL prior to admission, making this consistent with the 10-14 day period seen overall for detox/withdrawal in the hundreds of cases coming through our website. Nothing is documented re follow up with these five patients.
Multiple
relapses are common in the majority of GHB addiction cases. Many describe that GHB leaves a “hole in your
soul.” Establishing a decent sleep
pattern is often a problem. Depression,
even at suicidal levels, is nearly standard.
Anxiety attacks are also ongoing.
Depression/anxiety typically decrease with time, taking a few weeks for
some and months or even years for others.
Many recovering addicts need medication at least temporarily to deal
with the sleep/depression/anxiety issues.
Those with prior depression seem to have the most difficulty finding a
regime of meds that work well after GHB use.
Accidental overdoses on other drugs, especially trying to detox without
adequate medical supervision, are common, sometimes resulting in death. These deaths may not be recognized as related
to GHB since there will be no GHB in their system. Suicides have been noted from 36 hours into
detox to several months later, whether or not there were prior depression or
mental health issues. Many have by now
lost jobs, financial security, family, and other relationships. Many do not see themselves as “addicts”
because of their unintentional involvement with this drug and shy away from
AA/NA meetings. They need to recognize
their status as indeed “addicted” and need understanding in treatment and
meetings to put aside this alienation.
As with any drug, acceptance of their addiction is crucial to
management.
For further information, please visit our website: www.projectghb.org. Doctors & facilities experienced w/GHB
withdrawal or willing to handle these cases are asked to contact us so that
they may be added to our referral list.
A research project is being conducted by Brown University. This study is about the effects of GHB/analogs among web-users. If you are interested in participating in this important research project, please log into 'http://www.caas.brown.edu/CED/Courses/GHB/ghbintro.html'. You will be asked to complete an anonymous survey via the web. Thank you.